RN7SL236P

Across TCGA pan-cancer cohorts, RN7SL236P RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RN7SL236P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RN7SL236P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL236P is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

THCA, KICH, and HNSC are the cancer types where RN7SL236P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL236P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	II,III,IV	−0.505	<.001	6	view →
KICH	All	All	−0.237	<.001	5	view →
HNSC	Male	All	+0.201	.019	5	view →
BRCA	All	II,III,IV	+0.267	<.001	4	view →
STAD	All	All	+0.190	.010	4	view →
PAAD	Male	All	−0.575	.006	2	view →
LUAD	All	All	+0.268	.032	1	view →
BLCA	All	III,IV	+0.263	.045	1	view →
CHOL	All	All	+0.247	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

RN7SL236P–THCA

Open the THCA breakdown →